These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 36075151)
1. Executive function in methamphetamine users with and without psychosis. Koopowitz SM; Cotton SM; Uhlmann A; Thomas KGF; Stein DJ Psychiatry Res; 2022 Nov; 317():114820. PubMed ID: 36075151 [TBL] [Abstract][Full Text] [Related]
2. Cognitive impairment in methamphetamine users with recent psychosis: A cross-sectional study in Thailand. Srisurapanont M; Lamyai W; Pono K; Indrakamhaeng D; Saengsin A; Songhong N; Khuwuthyakorn P; Jantamo P Drug Alcohol Depend; 2020 May; 210():107961. PubMed ID: 32302795 [TBL] [Abstract][Full Text] [Related]
3. Persistence of psychotic symptoms as an indicator of cognitive impairment in methamphetamine users. Chen CK; Lin SK; Chen YC; Huang MC; Chen TT; Ree SC; Wang LJ Drug Alcohol Depend; 2015 Mar; 148():158-64. PubMed ID: 25601645 [TBL] [Abstract][Full Text] [Related]
4. The cognitive impairments and psychological wellbeing of methamphetamine dependent patients compared with health controls. Zhong N; Jiang H; Du J; Zhao Y; Sun H; Xu D; Li C; Zhuang W; Li X; Hashimoto K; Zhao M Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():31-7. PubMed ID: 27085943 [TBL] [Abstract][Full Text] [Related]
5. Longer term improvement in neurocognitive functioning and affective distress among methamphetamine users who achieve stable abstinence. Iudicello JE; Woods SP; Vigil O; Scott JC; Cherner M; Heaton RK; Atkinson JH; Grant I; J Clin Exp Neuropsychol; 2010 Aug; 32(7):704-18. PubMed ID: 20198527 [TBL] [Abstract][Full Text] [Related]
6. Cognition during active methamphetamine use versus remission. Huckans M; Boyd S; Moncrief G; Hantke N; Winters B; Shirley K; Sano E; McCready H; Dennis L; Kohno M; Hoffman W; Loftis JM J Clin Exp Neuropsychol; 2021 Aug; 43(6):599-610. PubMed ID: 34612792 [TBL] [Abstract][Full Text] [Related]
7. Social cognition and aggression in methamphetamine dependence with and without a history of psychosis. Uhlmann A; Ipser JC; Wilson D; Stein DJ Metab Brain Dis; 2018 Apr; 33(2):559-568. PubMed ID: 29224181 [TBL] [Abstract][Full Text] [Related]
8. Executive control deficits in substance-dependent individuals: a comparison of alcohol, cocaine, and methamphetamine and of men and women. van der Plas EA; Crone EA; van den Wildenberg WP; Tranel D; Bechara A J Clin Exp Neuropsychol; 2009 Aug; 31(6):706-19. PubMed ID: 19037812 [TBL] [Abstract][Full Text] [Related]
9. Elevated intraindividual variability in methamphetamine dependence is associated with poorer everyday functioning. Morgan EE; Doyle KL; Minassian A; Henry BL; Perry W; Marcotte TD; Woods SP; Grant I; Psychiatry Res; 2014 Dec; 220(1-2):527-34. PubMed ID: 25081313 [TBL] [Abstract][Full Text] [Related]
10. Cognitive deficits in methamphetamine addiction: Independent contributions of dependence and intelligence. Fitzpatrick RE; Rubenis AJ; Lubman DI; Verdejo-Garcia A Drug Alcohol Depend; 2020 Apr; 209():107891. PubMed ID: 32061948 [TBL] [Abstract][Full Text] [Related]
11. Neuropsychological function and delay discounting in methamphetamine-dependent individuals. Hoffman WF; Moore M; Templin R; McFarland B; Hitzemann RJ; Mitchell SH Psychopharmacology (Berl); 2006 Oct; 188(2):162-70. PubMed ID: 16915378 [TBL] [Abstract][Full Text] [Related]
12. Methamphetamine dependence and neuropsychological functioning: evaluating change during early abstinence. Simon SL; Dean AC; Cordova X; Monterosso JR; London ED J Stud Alcohol Drugs; 2010 May; 71(3):335-44. PubMed ID: 20409426 [TBL] [Abstract][Full Text] [Related]
13. Cognitive profile of ketamine-dependent patients compared with methamphetamine-dependent patients and healthy controls. Wang LJ; Chen CK; Lin SK; Chen YC; Xu K; Huang MC Psychopharmacology (Berl); 2018 Jul; 235(7):2113-2121. PubMed ID: 29713787 [TBL] [Abstract][Full Text] [Related]
14. Neurocognitive deficits are associated with unemployment in chronic methamphetamine users. Weber E; Blackstone K; Iudicello JE; Morgan EE; Grant I; Moore DJ; Woods SP; Drug Alcohol Depend; 2012 Sep; 125(1-2):146-53. PubMed ID: 22560676 [TBL] [Abstract][Full Text] [Related]
15. Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders. McKetin R; Baker AL; Dawe S; Voce A; Lubman DI Psychiatry Res; 2017 May; 251():349-354. PubMed ID: 28282630 [TBL] [Abstract][Full Text] [Related]
16. Risks of psychosis in methamphetamine users: cross-sectional study in Thailand. Lamyai W; Pono K; Indrakamhaeng D; Saengsin A; Songhong N; Khuwuthyakorn P; Sribanditmongkol P; Junkuy A; Srisurapanont M BMJ Open; 2019 Oct; 9(10):e032711. PubMed ID: 31615802 [TBL] [Abstract][Full Text] [Related]
17. Clinical course and outcomes of methamphetamine-dependent adults with psychosis. Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson R; J Subst Abuse Treat; 2008 Dec; 35(4):445-50. PubMed ID: 18294802 [TBL] [Abstract][Full Text] [Related]
18. Neuropsychological deficits in adolescent methamphetamine abusers. King G; Alicata D; Cloak C; Chang L Psychopharmacology (Berl); 2010 Oct; 212(2):243-9. PubMed ID: 20640405 [TBL] [Abstract][Full Text] [Related]
19. Drug-related decrease in neuropsychological functions of abstinent drug users. van Holst RJ; Schilt T Curr Drug Abuse Rev; 2011 Mar; 4(1):42-56. PubMed ID: 21466500 [TBL] [Abstract][Full Text] [Related]
20. Primary and substance-induced psychotic disorders in methamphetamine users. Hides L; Dawe S; McKetin R; Kavanagh DJ; Young RM; Teesson M; Saunders JB Psychiatry Res; 2015 Mar; 226(1):91-6. PubMed ID: 25677394 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]